Skip to main content
Equibles
EVH logo

EVH · Evolent Health, Inc. · Metrics

Track EVH — free

Use EVH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EVH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.83 -0.04 (-0.82%)
Russell 2000 member Rebalance outlook locked
Market Cap
$550.60M
Shares
113.06M
Volume · Oct 21 1.47M Avg daily vol (3M) 2.98M

EVH metrics

88 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.83
Market cap
$550.60M

Price action

20 metrics
Price change (1W)
+5.9%
Price change (30D)
+32.0%
Price change (3M)
-16.8%
Price change (6M)
+54.6%
Price change (YTD)
+21.8%
Price change (1Y)
-37.2%
Trailing year
Price change (5Y)
-83.5%
52-week high
$8.18
52-week low
$2.17
Change from 52-week high
-40.5%
Change from 52-week low
+124.4%
Annualized volatility
81.2%
Annualized volatility (3M)
85.7%
Beta
1.1
RSI (14D)
65.6
Price vs SMA 50
+16.3%
Price vs SMA 200
+26.5%
Avg volume (3M)
3.00M
Relative volume
0.4
Average dollar volume
$12.26M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
113.06M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.7×
reciprocal yield 153.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 380.9%
P / book
1.4
reciprocal yield 69.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
10.1
reciprocal yield 9.9%
Earnings yield
-91.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.9×
reciprocal yield 109.1%
EV / revenue historical average (5Y)
1.5×
reciprocal yield 68.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
27.6×
reciprocal yield 3.6%
EV / EBITDA historical average (5Y)
62.1×
reciprocal yield 1.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
17.2%
Operating margin
-20.4%
Trailing 12 months
Net margin
-24.1%
Gross profit (TTM)
$361.64M
Operating profit (TTM)
−$427.50M
Net income (TTM)
−$504.99M
Trailing 12 months
Diluted EPS (TTM)
$-4.57
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$18.64
Gross profit per diluted share (TTM)
$3.21
Operating profit per diluted share (TTM)
$-3.83
EBITDA per diluted share (TTM)
$-2.83
Net income per diluted share (TTM)
$-4.52
Operating cash flow per diluted share (TTM)
$0.48
Free cash flow per diluted share (TTM)
$-0.96
Capital expenditures per diluted share (TTM)
$0.43
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.38
Book value per share
$10.98

Growth

11 metrics
Revenue growth YoY
+46.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.10B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-2.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+11.5%
Revenue CAGR (5Y)
+15.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-131.8%
Return on assets
-25.6%
Debt / equity
2.3
Current ratio
1.2
EBITDA (TTM)
−$315.73M
Free cash flow (TTM)
—
Quick ratio
1.2
Interest coverage
-6.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$818.68M
Latest balance sheet
Cash & equivalents
$115.70M
Total assets
$1.97B
Total debt
$970.54M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$54.32M
Capital expenditures (TTM)
$35.53M
R&D (TTM)
$16.10M
SG&A (TTM)
$291.90M
Stock compensation (TTM)
$42.93M
R&D / revenue
—
Stock compensation / revenue
2.0%

Ownership (13F)

9 metrics
13F filers
199
13F filer change QoQ
+6
Institutional ownership
99.7%
Conviction holders (share of 13F filers)
2.0%
Crowding (high-turnover and private-fund holders)
45.4%
Private-fund adviser ownership
39.5%
Active holders' share change QoQ
-7.6%
Holder tenure
13.6
Price vs estimated holder cost
-45.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
14.0%

Short interest

3 metrics
Short interest
11.4%
Latest settlement · 5.5 days to cover
Days to cover
5.5d
Short-squeeze score
73 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$329,460
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1628908 CUSIP 30050B101 13F (30d) 13 filings 13 filers Visit website Investor relations